Olson covers the Healthcare sector, focusing on stocks such as Enanta Pharmaceuticals, Axovant Gene Therapies, and CymaBay Therapeutics. Intercept Pharma has an analyst consensus of Strong Buy, with a …
More Intercept Pharma (ICPT) Receives a Buy from Oppenheimer Videos